Feb 17, 2023 8:30 am EST VolitionRx Limited Announces Pricing of $7.525 Million Underwritten Public Offering of Common Stock
Feb 16, 2023 4:10 pm EST VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock
Feb 16, 2023 8:00 am EST Volition's Nu.Q® Vet Cancer Test Now Available for Pre-Order at The Point-of-Care Through Heska Corporation
Jan 12, 2023 8:29 am EST Volition Announces Expansion of Availability of the Nu.Q® Vet Cancer Test Through IDEXX's Reference Laboratory Network
Nov 14, 2022 4:10 pm EST VolitionRx Limited Announces Third Quarter 2022 Financial Results and Business Update
Nov 9, 2022 8:30 am EST VolitionRx Limited Schedules Third Quarter 2022 Earnings Conference Call and Business Update
